Literature DB >> 22651555

Biomarkers and biomeasures: key enablers for pharmacokinetic-pharmacodynamic modeling in drug discovery and development.

Balaji M Agoram, Piet H van der Graaf.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22651555     DOI： 10.4155/bio.12.88

Source DB:  PubMed          Journal:  Bioanalysis        ISSN： 1757-6180            Impact factor:   2.681


× No keyword cloud information.
  3 in total

1.  Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotin.

Authors:  Dhaval K Shah; Nahor Haddish-Berhane; Alison Betts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-11-15       Impact factor: 2.745

Review 2.  Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm.

Authors:  A Taneja; O Della Pasqua; M Danhof
Journal:  Eur J Clin Pharmacol       Date:  2017-09-11       Impact factor: 2.953

3.  A pharmacokinetics-pharmacodynamics study of single-dose total glucosides of paeony capsule on reducing serum total bile acid in hepatic injury rats.

Authors:  Ninghua Jiang; Bohong Zheng; Yihan Feng; Lei Yin; Yuanrong Liu; Lujing Cao; Ning Zheng; Suxiang Wu; Baoyue Ding; Xuan Huang; Jeffrey Wang; Shuyu Zhan
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.